期刊的影响因子--文章列表

期刊文章列表
Jissy Vijo Poulose¹，Cessal Thommachan Kainickal²（National Fellowship in Palliative Medicine (Training Program)，Institute of Palliative Medicine；Department of Radiation Oncology，Regional Cancer Centre）.Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials[J].World Journal of Clinical Oncology,2022,第5期 Carlos Aguado¹，Luis Chara²，Mónica Anto?anzas¹，Jose Maria Matilla Gonzalez³，Unai Jiménez⁴，Raul Hernanz⁵，Xabier Mielgo-Rubio⁶，Juan Carlos Trujillo-Reyes^7,8，Felipe Cou?ago^9,10,11（Department of Medical Oncology，Hospital Clínico Universitario San Carlos；Department of Medical Oncology，Hospital Universitario de Guadalajara；Department of Thoracic Surgery，Hospital Clínico Universitario de Valladolid；Department of Thoracic Surgery，Hospital Universitario Cruces，Barakaldo；Department of Radiation Oncology，Hospital Universitario Ramón y Cajal；Department of Medical Oncology，Hospital Universitario Fundación Alcorcón；Department of Thoracic Surgery，Hospital de la Santa Creu Ⅰ Sant Pau；Department of Surgery，Universitat Autonoma de Barcelona；Department of Radiation Oncology，Hospital Universitario Quirónsalud Madrid；Department of Radiation Oncology，Hospital La Luz；Medicine Department，School of Biomedical Sciences，Universidad Europea de Madrid）.Neoadjuvant treatment in non-small cell lung cancer: New perspectives with the incorporation of immunotherapy[J].World Journal of Clinical Oncology,2022,第5期 Michael Goutnik，Brandon Lucke-Wold（Department of Neurosurgery，University of Florida）.Commentary: Evaluating potential glioma serum biomarkers, with future applications[J].World Journal of Clinical Oncology,2022,第5期 Tomoki Sempokuya¹，Arnold Forlemu¹，Muaataz Azawi²，Krixie Silangcruz³，Nathalie Khoury¹，Jihyun Ma⁴，Linda L Wong⁵（Division of Gastroenterology and Hepatology，Department of Internal Medicine，University of Nebraska Medical Center；Division of Gastroenterology and Hepatology，Sanford Center for Digestive Health；Department of Medicine，John A.Burns School of Medicine，University of Hawaii at Manoa；Department of Biostatistics，College of Public Health，University of Nebraska Medical Center；Department of Surgery，John A.Burns School of Medicine，University of Hawaii at Manoa）.Survival characteristics of fibrolamellar hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results database study[J].World Journal of Clinical Oncology,2022,第5期 Frank-Un Hong，Miguel Castro，Klaus Linse（Research ＆ Development，Bio-Synthesis，Inc.）.Tumor specifically internalizing peptide ‘HN-1’: Targeting the putative receptor retinoblastoma-regulated discoidin domain receptor 1 involved in metastasis[J].World Journal of Clinical Oncology,2022,第5期 Andrea Pretta¹，Dario Spanu¹，Stefano Mariani¹，Nicole Liscia²，Pina Ziranu¹，Valeria Pusceddu¹，Marco Puzzoni¹，Elena Massa¹，Mario Scartozzi¹，Eleonora Lai¹（Medical Oncology Unit，University Hospital and University of Cagliari；Department of Oncology，IRCCS San Raffaele Scientific Institute Hospital，VitaSalute San Raffaele University）.How to improve metastatic pancreatic ductal adenocarcinoma patients’ selection: Between clinical trials and the real-world[J].World Journal of Clinical Oncology,2022,第5期 Satyaprakash Ray Choudhury，Raja Kalayarasan，Senthil Gnanasekaran，Biju Pottakkat（Department of Surgical Gastroenterology，Jawaharlal Institute of Postgraduate Medical Education and Research）.Modified binding pancreaticogastrostomy vs modified Blumgart pancreaticojejunostomy after laparoscopic pancreaticoduodenectomy for pancreatic or periampullary tumors[J].World Journal of Clinical Oncology,2022,第5期 Maria Eugenia Olmedo¹；Raquel Cervera²；Luis Cabezon-Gutierrez³；Yolanda Lage¹；Elena Corral de la Fuente⁴；Ana Gómez Rueda¹；Xabier Mielgo-Rubio⁵；Juan Carlos Trujillo^6,7；Felipe Cou?ago^8,9,10（Department of Medical Oncology, Ramón y Cajal University Hospital；Department of Medical Oncology, Del Henares University Hospital；Medical Oncology, Hospital Universitario de Torrejón；Medical Oncology Department, Hospital Universitario Ramon y Cajal；Department of Medical Oncology, Foundation Alcorcón University Hospital；Department Thoracic Surgery, Hospital de la Santa Creu I Sant Pau；Department of Surgery, Universitat Autonoma de Barcelona；Department of Radiation Oncology, Hospital Universitario Quirónsalud Madrid；Department of Radiation Oncology, Hospital La Luz；Medicine Department, School of Biomedical Sciences, Universidad Europea de Madrid）.New horizons for uncommon mutations in non-small cell lung cancer:BRAF,KRAS,RET,MET,NTRK,HER2[J].World Journal of Clinical Oncology,2022,第4期 Núria Rodríguez De Dios^1,2,3；Arturo Navarro-Martin；Cristina Cigarral⁵；Rodolfo Chicas-Sett⁶；Rafael García⁷；Virginia Garcia⁸；Jose Antonio Gonzalez⁹；Susana Gonzalo¹⁰；Mauricio Murcia-Mejía¹¹；Rogelio Robaina⁸；Amalia Sotoca⁷；Carmen Vallejo¹²；German Valtue?a¹³；Felipe Cou?ago^14,15,16（Department of Radiation Oncology, Hospital del Mar；Radiation Oncology Research Group, Hospital Del Mar Medical Research Institution；Department of Experimental and Health Sciences, Pompeu Fabra University；Department of Radiation Oncology, Thoracic Malignancies Unit, Hospital Duran i Reynals. ICO, L’ Hospitalet de L；Department of Radiation Oncology, Hospital Clínico de Salamanca；Department of Radiation Oncology, ASCIRES Grupo Biomédico；Department of Radiation Oncology, Hospital Ruber Internacional；Department of Radiation Oncology, Hospital Universitario Arnau de Vilanova；Department of Radiation Oncology, Genesis Care-Spain；Department of Radiation Oncology, Hospital Universitario La Princesa；Department of Radiation Oncology, Hospital Universitario Sant Joan de Reus；Department of Radiation Oncology, Hospital Universitario Ramón y Cajal；Department of Radiation Oncology, Hospital Clínico Universitario Lozano Blesa；Department of Radiation Oncology, Hospital Universitario Quirónsalud；Department of Radiation Oncology, Hospital La Luz；Department of Clinical, Universidad Europea）.GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer[J].World Journal of Clinical Oncology,2022,第4期 Xabier Mielgo-Rubio¹；Ana Carde?a Gutiérrez²；Verónica Sotelo Pe?a³；Maria Virginia Sánchez Becerra¹；Andrea María González López¹；Adriana Rosero⁴；Juan Carlos Trujillo-Reyes⁵；Felipe Cou?ago^6,7,8（Department of Medical Oncology, Hospital Universitario Fundación Alcorcón；Department of Medical Oncology, Hospital Universitario Nuestra Se? ora de Candelaria, Santa Cruz de Tenerife；Department of Medical Oncology, Hospital Virgen de La Luz；Department of Medical Oncology, Hospital Universitario Del Henares；Department of Thoracic Surgery, Hospital Universitari de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona；Department of Radiation Oncology, Hospital Universitario Quirónsalud Madrid；Department of Radiation Oncology, Hospital La Luz；Medicine Department, Universidad Europea de Madrid）.Tsunami of immunotherapy reaches mesothelioma[J].World Journal of Clinical Oncology,2022,第4期 Justine Perrin¹，Karim Farid¹，Hilde Van Parijs²，Olena Gorobets³，Vincent Vinh-Hung^2,4，Nam P Nguyen⁵，Navid Djassemi^6,7，Mark De Ridder²，Hendrik Everaert⁸（Nuclear Medicine，CHU de Martinique Department of Radiotherapy，UZ Brussel Head and Neck Surgery，CHU de Martinique Department of Radiotherapie，Centre Hospitalier de Polynésie fran?aise；Department of Radiation Oncology，Howard University；Department of Pediatry，Hackensack University Medical Center；Rady Children's Hospital，University of California San Diego；Department of Nuclear Medicine）.ls there utility for fluorine-18-fluorodeoxyglucose positron-emission tomography scan before surgery in breast cancer?A 15-year overall survival analysis[J].World Journal of Clinical Oncology,2022,第4期 Chong-Chi Chiu^1,2,3，Haruaki Ishibashi⁴，Satoshi Wakama⁴，Yang Liu⁴，Yuan Hao⁵，Chao-Ming Hung^1,2，Po-Huang Lee^6,7，Kun-Ming Rau^2,8，Hui-Ming Lee^1,7，Yutaka Yonemura⁴（Department of General Surgery，E-Da Cancer Hospital；School of Medicine，College of Medicine，I-Shou University；Department of Medical Education and Research，E-Da Cancer Hospital；Peritoneal Surface Malignancy Center，Kishiwada Tokushukai Hospital；Department of General Surgery，Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine；Department of General Surgery，E-Da Hospital；College of Medicine，I-Shou University；Department of Hematology & Oncology，E-Da Cancer Hospital）.Mesentery solitary fibrous tumor with postoperative recurrence and sarcomatosis:A case report and review of literature[J].World Journal of Clinical Oncology,2022,第4期 Kaan Demiroren（Department of Pediatric Gastroenterology，University of Health Sciences，Yuksek Ihtisas Teaching Hospital）.Possible relationship between refractory celiac disease and malignancies[J].World Journal of Clinical Oncology,2022,第3期 Vinícius Lima de Souza Gon?alves¹，Maria Luísa Cordeiro Santos²，Marcel Silva Luz²，Hanna Santos Marques¹，Breno Bittencourt de Brito²，Filipe Ant?nio Fran?a da Silva²，Cláudio Lima Souza²，Márcio Vasconcelos Oliveira²，Fabrício Freire de Melo²（Universidade Estadual do Sudoeste da Bahia，Campus Vitória da Conquista；Universidade Federal da Bahia，Instituto Multidisciplinar em Saúde）.From Helicobacter pylori infection to gastric cancer: Current evidence on the immune response[J].World Journal of Clinical Oncology,2022,第3期 Julia Swoboda¹，Patrick Mittelsdorf¹，Yuan Chen¹，Ralf Weiskirchen²，Johannes Stallhofer³，Silke Schüle⁴，Nikolaus Gassler¹（Section Pathology，Institute of Forensic Medicine，Jena University Hospital；Institute of Molecular Pathobiochemistry，Experimental Gene Therapy and Clinical Chemistry，RWTH University Hospital Aachen；Department of Internal Medicine IV (Gastroenterology，Hepatology，and Infectious Diseases)，Jena University Hospital；Department of General，Visceral and Vascular Surgery，Jena University Hospital）.Intestinal Wnt in the transition from physiology to oncology[J].World Journal of Clinical Oncology,2022,第3期 Francisco Schlottmann¹，María A Casas¹，Daniela Molena²（Department of Surgery，Hospital Alemán of Buenos Aires；Department of Surgery，Memorial Sloan Kettering Cancer Center）.Evidence-based approach to the treatment of esophagogastric junction tumors[J].World Journal of Clinical Oncology,2022,第3期 Guillermo Arturo Valencia，Patricia Rioja，Zaida Morante，Rossana Ruiz，Hugo Fuentes，Carlos A Castaneda，Tatiana Vidaurre，Silvia Neciosup，Henry L Gomez（Department of Medical Oncology，Instituto Nacional de Enfermedades Neoplásicas）.Immunotherapy in triple-negative breast cancer: A literature review and new advances[J].World Journal of Clinical Oncology,2022,第3期 Ravi Mehrotra^1,2，Kavita Yadav³（Department of Health Research,Ministry of Health and Family Welfare,India Cancer Research Consortium；CHIP Foundation；Centre of Social Medicine & Community Health,Jawahar Lal Nehru University）.Breast cancer in India: Present scenario and the challenges ahead[J].World Journal of Clinical Oncology,2022,第3期 Agustín Falco¹，Mariano Leiva¹，Albano Blanco²，Guido Cefarelli²，Andrés Rodriguez²，Juan Melo³，Federico Cayol³，Manglio Miguel Rizzo⁴，Alejandro Sola⁵，Hernán Rodríguez Montani⁶，Matías Chacon²，Diego Enrico²，Federico Waisberg²（Department of Medical Oncology,Head and Neck Unit,Alexander Fleming Cancer Institute；Department of Medical Oncology,Alexander Fleming Cancer Institute；Department of Medical Oncology,Hospital Italiano de Buenos Aires；Department of Medical Oncology,Hospital Universitario Austral；Department of Medical Oncology,Fundación Centro Oncológico de Integración Regional；Department of Medical Oncology,Hospital Italiano Rosario Sanatorio de la Mujer）.First-line cisplatin,docetaxel,and cetuximab for patients with recurrent or metastatic head and neck cancer:A multicenter cohort study[J].World Journal of Clinical Oncology,2022,第2期 Daniel María Lubián López（Department of Mother and Child Health and Radiology，Faculty of Medicine，University of Cadiz；Department of Obstetrics and Gynecology Service，University Hospital of Jerez de la Frontera；Department of Obstetrics and Gynecology，Hospital Viamed Bahía de Cádiz；Department of Obstetrics and Gynecology，Hospital Quirónsalud Campo de Gibraltar）.Management of genitourinary syndrome of menopause in breast cancer survivors:An update[J].World Journal of Clinical Oncology,2022,第2期 Athina Stravodimou¹，Ioannis A Voutsadakis²（Department of Medical Oncology，CHUV；Department of Medical Oncology，Sault Area Hospital）.Neurotrophic receptor tyrosine kinase family members in secretory and non-secretory breast carcinomas[J].World Journal of Clinical Oncology,2022,第2期 Hossein Haghbin¹，Muhammad Aziz²（Department of Gastroenterology，Ascension Providence Southfield；Department of Gastroenterology，University of Toledo Medical Center）.Artificial intelligence and cholangiocarcinoma:Updates and prospects[J].World Journal of Clinical Oncology,2022,第2期 Omer Sager，Ferrat Dincoglan，Selcuk Demiral，Hakan Gamsiz，Bora Uysal，Fatih Ozcan，Onurhan Colak，Esra Gumustepe，Yelda Elcim，Esin Gundem，Bahar Dirican，Murat Beyzadeoglu（Gulhane Medical Faculty Department of Radiation Oncology，University of Health Sciences）.Optimal timing of thoracic irradiation for limited stage small cell lung cancer:Current evidence and future prospects[J].World Journal of Clinical Oncology,2022,第2期 Castalia Fernández¹；Arturo Navarro-Martin；Andrea Bobo³；Joaquín Cabrera-Rodriguez⁴；Patricia Calvo⁵；Rodolfo Chicas-Sett⁶；Javier Luna⁷；Nuria Rodríguez de Dios⁸；Felipe Cou?ago^9,10,11（Department of Radiation Oncology,Genesis Care Madrid；Department of Radiation Oncology,Institut Catalá d’Oncologia,L’Hospitalet de Llobregat；Department of Radiation Oncology,Hospital Ruber Internacional；Department of Radiation Oncology,Hospital Universitario de Badajoz；Department of Radiation Oncology,Hospitalario Clínico Universitario de Santiago de Compostela；Department of Radiation Oncology,ASCIRES Grupo Biomédico；Department of Radiation Oncology,Hospital Fundación Jiménez Díaz；Department of Radiation Oncology,Hospital del Mar；Department of Radiation Oncology,Hospital Universitario Quirónsalud Madrid；Department of Radiation Oncology,Hospital La Luz；Department of Medicine,School of Biomedical Sciences,Universidad Europea）.Single-fraction stereotactic ablative body radiation therapy for primary and metastasic lung tumor:A new paradigm?[J].World Journal of Clinical Oncology,2022,第2期 Maja Popovic^1,2，Gorana Matovina-Brko²，Masa Jovic²，Lazar S Popovic^1,2（Department of Medical Oncology；Faculty of Medicine）.Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma[J].World Journal of Clinical Oncology,2022,第1期 Fabián Pitoia¹，Fernando Jerkovich¹，Pierpaolo Trimboli^2,3，Anabella Smulever¹（Division of Endocrinology；Clinic for Endocrinology and Diabetology；Faculty of Biomedical Sciences）.New approaches for patients with advanced radioiodine-refractory thyroid cancer[J].World Journal of Clinical Oncology,2022,第1期 Rafael Antonio Medina López¹，Ines Rivero Belenchon²，Javier Mazuecos-Quirós¹，Carmen Belén Congregado-Ruíz¹，Felipe Cou?ago³（Department of Urology and Nephrology；Department of Urology and Nephrology；Radiation Oncology）.Update on the treatment of metastatic renal cell carcinoma[J].World Journal of Clinical Oncology,2022,第1期 Caglayan Selenge Beduk Esen，Melis Gultekin，Ferah Yildiz（Department of Radiation Oncology）.Role of radiotherapy in oligometastatic breast cancer: Review of the literature[J].World Journal of Clinical Oncology,2022,第1期 Abinav Baweja，Nataliya Mar，Arash Rezazadeh Kalebasty（Hematology/Oncology）.Late recurrence of localized pure seminoma in prostate gland: A case report[J].World Journal of Clinical Oncology,2022,第1期 Muhammad S Faisal¹，Carol A Burke²，David Liska³，Amy L Lightner³，Brandie Leach⁴，Margaret O'Malley³，Lisa LaGuardia³，Benjamin Click⁵，JP Achkar⁶，Matthew Kalady⁷，JM Church³，Gautam Mankaney⁸（Department of Internal Medicine；Department of Gastroenterology and Hepatology；Department of Colorectal Surgery；Center for Personalized Genetic Healthcare；Department of Gastroenterology；Center for Inflammatory Bowel Disease；Department of Colorectal Surgery；Department of Gastroenterology and Hepatology）.Association of cancer with comorbid inflammatory conditions and treatment in patients with Lynch syndrome[J].World Journal of Clinical Oncology,2022,第1期首页上一页 1 2 3 尾页共有3页，转到页

期刊文章列表